Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Asahi discloses anxiolytic/cognition-enhancing drugs

May 3, 1996

Teijin reports vitamin D3 derivatives for osteoporosis

May 3, 1996

Toray's MIP for treatment of ophthalmological disorders

May 3, 1996

EPC-K claimed for ophthalmic use

May 3, 1996

Hybridon reports oligonucleotide MDR inhibitors

May 3, 1996

Sankyo macrophage activators claimed as immunostimulants, antineoplastics

May 3, 1996

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

Fujisawa reports collagenase inhibitors

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Malaria vaccine lead reported by Johns Hopkins

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...